| Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema MJ Elman, LP Aiello, RW Beck, NM Bressler, SB Bressler, AR Edwards, ... Ophthalmology 117 (6), 1064-1077. e35, 2010 | 1792 | 2010 |
| Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. JA Wells, AR Glassman, AR Ayala, LM Jampol, LP Aiello, AN Antoszyk, ... The New England journal of medicine 372 (13), 1193-1203, 2015 | 1470 | 2015 |
| Diabetic retinopathy: a position statement by the American Diabetes Association SD Solomon, E Chew, EJ Duh, L Sobrin, JK Sun, BL VanderBeek, ... Diabetes care 40 (3), 412, 2017 | 938 | 2017 |
| Diabetic retinopathy: current understanding, mechanisms, and treatment strategies EJ Duh, JK Sun, AW Stitt JCI insight 2 (14), 2017 | 935 | 2017 |
| Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema MJ Elman, NM Bressler, H Qin, RW Beck, FL Ferris III, SM Friedman, ... Ophthalmology 118 (4), 609-614, 2011 | 758 | 2011 |
| Guidelines on diabetic eye care: the international council of ophthalmology recommendations for screening, follow-up, referral, and treatment based on resource settings TY Wong, J Sun, R Kawasaki, P Ruamviboonsuk, N Gupta, VC Lansingh, ... Ophthalmology 125 (10), 1608-1622, 2018 | 649 | 2018 |
| Residual insulin production and pancreatic β-cell turnover after 50 years of diabetes: Joslin Medalist Study HA Keenan, JK Sun, J Levine, A Doria, LP Aiello, G Eisenbarth, ... Diabetes 59 (11), 2846-2853, 2010 | 618 | 2010 |
| Panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial JG Gross, AR Glassman, LM Jampol, S Inusah, LP Aiello, AN Antoszyk, ... Jama 314 (20), 2137-2146, 2015 | 572 | 2015 |
| Disorganization of the retinal inner layers as a predictor of visual acuity in eyes with center-involved diabetic macular edema JK Sun, MM Lin, J Lammer, S Prager, R Sarangi, PS Silva, LP Aiello JAMA ophthalmology 132 (11), 1309-1316, 2014 | 507 | 2014 |
| Five-year outcomes of panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial JG Gross, AR Glassman, D Liu, JK Sun, AN Antoszyk, CW Baker, ... JAMA ophthalmology 136 (10), 1138-1148, 2018 | 358 | 2018 |
| Peripheral lesions identified on ultrawide field imaging predict increased risk of diabetic retinopathy progression over 4 years PS Silva, JD Cavallerano, NMN Haddad, H Kwak, KH Dyer, AF Omar, ... Ophthalmology 122 (5), 949-956, 2015 | 321 | 2015 |
| Peripheral lesions identified by mydriatic ultrawide field imaging: distribution and potential impact on diabetic retinopathy severity PS Silva, JD Cavallerano, JK Sun, AZ Soliman, LM Aiello, LP Aiello Ophthalmology 120 (12), 2587-2595, 2013 | 314 | 2013 |
| A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes MA Niewczas, ME Pavkov, J Skupien, A Smiles, ZI Md Dom, JM Wilson, ... Nature medicine 25 (5), 805-813, 2019 | 301 | 2019 |
| Clinical factors associated with resistance to microvascular complications in diabetic patients of extreme disease duration: the 50-year medalist study HA Keenan, T Costacou, JK Sun, A Doria, J Cavellerano, J Coney, ... Diabetes care 30 (8), 1995-1997, 2007 | 290 | 2007 |
| Protection from retinopathy and other complications in patients with type 1 diabetes of extreme duration: the joslin 50-year medalist study JK Sun, HA Keenan, JD Cavallerano, BF Asztalos, EJ Schaefer, DR Sell, ... Diabetes care 34 (4), 968-974, 2011 | 284 | 2011 |
| Nonmydriatic ultrawide field retinal imaging compared with dilated standard 7-field 35-mm photography and retinal specialist examination for evaluation of diabetic retinopathy PS Silva, JD Cavallerano, JK Sun, J Noble, LM Aiello, LP Aiello American journal of ophthalmology 154 (3), 549-559. e2, 2012 | 264 | 2012 |
| Effect of initial management with aflibercept vs laser photocoagulation vs observation on vision loss among patients with diabetic macular edema involving the center of the … CW Baker, AR Glassman, WT Beaulieu, AN Antoszyk, DJ Browning, ... Jama 321 (19), 1880-1894, 2019 | 250 | 2019 |
| Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two … CC Wykoff, F Abreu, AP Adamis, K Basu, DA Eichenbaum, Z Haskova, ... The Lancet 399 (10326), 741-755, 2022 | 242 | 2022 |
| Effect of adding dexamethasone to continued ranibizumab treatment in patients with persistent diabetic macular edema: a DRCR network phase 2 randomized clinical trial RK Maturi, AR Glassman, D Liu, RW Beck, AR Bhavsar, NM Bressler, ... JAMA ophthalmology 136 (1), 29-38, 2018 | 240 | 2018 |
| Diabetic retinopathy severity and peripheral lesions are associated with nonperfusion on ultrawide field angiography PS Silva, AJD Cruz, MG Ledesma, J van Hemert, A Radwan, ... Ophthalmology 122 (12), 2465-2472, 2015 | 234 | 2015 |
